A citation-based method for searching scientific literature

Antoine Boureille, Carole Ferraro-Peyret, Guillaume Pontarollo, Cyrille Confavreux, Jean-Baptiste Pialat, Sylvie Isaac, Fabien Forest, Violaine Yvorel, Emmanuel Watkin, Nicolas Girard, Marie Brevet. J Bone Oncol 2020
Times Cited: 7







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced sensitivity for EGFR T790M mutations using the Idylla EGFR Mutation Test.
Eric Lee, Victoria Jones, Eleni Topkas, James Harraway. J Clin Pathol 2021
13
71

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
Mercedes Delgado-García, Birgit Weynand, Lourdes Gómez-Izquierdo, María José Hernández, Ángela María Blanco, Mar Varela, Xavier Matias-Guiu, Ernest Nadal, Bélgica Márquez-Lobo, Ana Alarcão,[...]. BMC Cancer 2020
10
71

Evaluation of a fast and fully automated platform to diagnose EGFR and KRAS mutations in formalin-fixed and paraffin-embedded non-small cell lung cancer samples in less than one day.
Laetitia Lambros, Charline Caumont, Briac Guibourg, Fanny Barel, Isabelle Quintin-Roué, Pascale Marcorelles, Jean-Philippe Merlio, Arnaud Uguen. J Clin Pathol 2017
32
71

Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Solène M Evrard, Estelle Taranchon-Clermont, Isabelle Rouquette, Samuel Murray, Sebastian Dintner, Yun-Chung Nam-Apostolopoulos, Beatriz Bellosillo, Mar Varela-Rodriguez, Ernest Nadal, Klaus H Wiedorn,[...]. J Mol Diagn 2019
27
71

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
Caterina De Luca, Alessandra G Rappa, Gianluca Gragnano, Umberto Malapelle, Giancarlo Troncone, Massimo Barberis. J Clin Pathol 2018
25
57

Rapid EGFR mutation testing in lung cancer tissue samples using a fully automated system and single-use cartridge.
M Rabie Al-Turkmani, Michael A Suriawinata, Sophie J Deharvengt, Donald C Green, Candice C Black, Keisuke Shirai, Konstantin H Dragnev, Gregory J Tsongalis. Pract Lab Med 2020
6
66

Evaluation of the Idylla system to detect the EGFRT790M mutation using extracted DNA.
Claire Bocciarelli, Justine Cohen, Romain Pelletier, Jeanne Tran Van Nhieu, Jonathan Derman, Loetitia Favre, Anaïs Bourgogne, Isabelle Monnet, Christos Chouaid, Anaïs Pujals. Pathol Res Pract 2020
15
57

Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine.
Huiya Huang, Stephanie Springborn, Kiefer Haug, Kaitlyn Bartow, Hasan Samra, Smitha Menon, Alexander C Mackinnon. J Mol Diagn 2019
19
57

Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.
Matthias Van Haele, Sara Vander Borght, An Ceulemans, Michiel Wieërs, Sofie Metsu, Xavier Sagaert, Birgit Weynand. J Clin Pathol 2020
23
57

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France).
Sandra Lassalle, Véronique Hofman, Simon Heeke, Jonathan Benzaquen, Elodie Long, Michel Poudenx, Elisabeth Lantéri, Jacques Boutros, Virginie Tanga, Katia Zahaf,[...]. Cancers (Basel) 2020
13
57

Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
Richard Colling, Hollie Bancroft, Gerald Langman, Elizabeth Soilleux. Virchows Arch 2019
19
57

[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].
Louise-Marie Chevalier, Amandine Billaud, Christophe Passot, Adélaïde Renoult, Frédéric Bigot, Véronique Verrièle, Alain Morel. Ann Pathol 2020
7
57

EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay.
Caterina De Luca, Gianluca Gragnano, Pasquale Pisapia, Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone. J Clin Pathol 2017
40
42

Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
Amir Momeni-Boroujeni, Paulo Salazar, Tao Zheng, Nana Mensah, Ivelise Rijo, Snjezana Dogan, JinYuan Yao, Christine Moung, Chad Vanderbilt, Jamal Benhamida,[...]. J Mol Diagn 2021
10
42

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.
Marius Ilie, Catherine Butori, Sandra Lassalle, Simon Heeke, Nicolas Piton, Jean-Christophe Sabourin, Virginie Tanga, Kevin Washetine, Elodie Long-Mira, Priscilla Maitre,[...]. Oncotarget 2017
38
42


Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study.
Caterina De Luca, Floriana Conticelli, Alvaro Leone, Gianluca Gragnano, Maria Salatiello, Pasqualina Galasso, Pasquale Pisapia, Lucia Rosalba Grillo, Antonino Iaccarino, Elena Vigliar,[...]. J Clin Pathol 2019
13
28

Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform.
Josè Nunnari, Paolo Graziano, Lucia Anna Muscarella, Antonio Rossi, Lucia Rosalba Grillo, Giuseppe Montrone, Angela Di Lorenzo, Monica Bronzini, Alvaro Leone. J Clin Pathol 2022
2
100


Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.
Pauline Gilson, Julien Levy, Marie Rouyer, Jessica Demange, Marie Husson, Céline Bonnet, Julia Salleron, Agnès Leroux, Jean-Louis Merlin, Alexandre Harlé. Sci Rep 2020
21
28

Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
Claire Franczak, Andréa Witz, Karen Geoffroy, Jessica Demange, Marie Rouyer, Marie Husson, Vincent Massard, Céline Gavoille, Aurélien Lambert, Pauline Gilson,[...]. PLoS One 2020
6
33

Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate.
Maria E Arcila, Soo-Ryum Yang, Amir Momeni, Douglas A Mata, Paulo Salazar, Roger Chan, Daniela Elezovic, Ryma Benayed, Ahmet Zehir, Darren J Buonocore,[...]. JTO Clin Res Rep 2020
11
28

EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Vincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, Antoinette Lemoine, Benjamin Besse, Olaf Mercier, Élie Fadel, Peter Dorfmuller, Thierry Le Chevalier. Pathol Res Pract 2017
15
28

Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers.
Pauline Gilson, Chloé Saurel, Julia Salleron, Marie Husson, Jessica Demange, Jean-Louis Merlin, Alexandre Harlé. Sci Rep 2021
2
100

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.
Glen Le Flahec, Briac Guibourg, Pascale Marcorelles, Arnaud Uguen. J Clin Pathol 2017
8
28

Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.
A C Sousa, C Silveira, A Janeiro, S Malveiro, A R Oliveira, M Felizardo, F Nogueira, E Teixeira, J Martins, M Carmo-Fonseca. Lung Cancer 2020
22
28

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System.
Simon Heeke, Véronique Hofman, Jonathan Benzaquen, Josiane Otto, Virginie Tanga, Katia Zahaf, Maryline Allegra, Elodie Long-Mira, Sandra Lassalle, Charles-Hugo Marquette,[...]. Front Pharmacol 2021
6
33

Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes.
Tiffany Haiduk, Michael Brockmann, Ramona-Liza Tillmann, Monika Pieper, Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen. Exp Mol Pathol 2021
3
66

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
28

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics.
Maria E Arcila, Khedoudja Nafa, Jamie E Chaft, Natasha Rekhtman, Christopher Lau, Boris A Reva, Maureen F Zakowski, Mark G Kris, Marc Ladanyi. Mol Cancer Ther 2013
280
14

Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses.
Tilak K Sundaresan, Lecia V Sequist, John V Heymach, Gregory J Riely, Pasi A Jänne, Walter H Koch, James P Sullivan, Douglas B Fox, Robert Maher, Alona Muzikansky,[...]. Clin Cancer Res 2016
277
14

Superior Multiplexing Capacity of PlexPrimers Enables Sensitive and Specific Detection of SNPs and Clustered Mutations in qPCR.
Lit Yeen Tan, Samantha Michelle Walker, Tina Lonergan, Nicole Elizabeth Lima, Alison Velyian Todd, Elisa Mokany. PLoS One 2017
14
14

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Mol Diagn 2013
345
14



Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.
Snjezana Dogan, Ronglai Shen, Daphne C Ang, Melissa L Johnson, Sandra P D'Angelo, Paul K Paik, Edyta B Brzostowski, Gregory J Riely, Mark G Kris, Maureen F Zakowski,[...]. Clin Cancer Res 2012
381
14

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.
Emmet J Jordan, Hyunjae R Kim, Maria E Arcila, David Barron, Debyani Chakravarty, JianJiong Gao, Matthew T Chang, Andy Ni, Ritika Kundra, Philip Jonsson,[...]. Cancer Discov 2017
348
14

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
14

Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience.
Shaozhou Ken Tian, J Keith Killian, Natasha Rekhtman, Ryma Benayed, Sumit Middha, Marc Ladanyi, Oscar Lin, Maria E Arcila. Arch Pathol Lab Med 2016
57
14

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.
Crispin T Hiley, John Le Quesne, George Santis, Rowena Sharpe, David Gonzalez de Castro, Gary Middleton, Charles Swanton. Lancet 2016
108
14

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.
Zoltan Lohinai, Mir Alireza Hoda, Katalin Fabian, Gyula Ostoros, Erzsebet Raso, Tamas Barbai, Jozsef Timar, Ilona Kovalszky, Mihaly Cserepes, Anita Rozsas,[...]. J Thorac Oncol 2015
62
14


Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients.
Simon R Turner, Darren Buonocore, Patrice Desmeules, Natasha Rekhtman, Snjezana Dogan, Oscar Lin, Maria E Arcila, David R Jones, James Huang. Lung Cancer 2018
26
14


Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Donavan T Cheng, Talia N Mitchell, Ahmet Zehir, Ronak H Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H Won, Sasinya N Scott,[...]. J Mol Diagn 2015
14

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay.
Maria E Arcila, Geoffrey R Oxnard, Khedoudja Nafa, Gregory J Riely, Stephen B Solomon, Maureen F Zakowski, Mark G Kris, William Pao, Vincent A Miller, Marc Ladanyi. Clin Cancer Res 2011
450
14


A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Yuankai Shi, Joseph Siu-Kie Au, Sumitra Thongprasert, Sankar Srinivasan, Chun-Ming Tsai, Mai Trong Khoa, Karin Heeroma, Yohji Itoh, Gerardo Cornelio, Pan-Chyr Yang. J Thorac Oncol 2014
821
14


Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.